Cargando…
Polynuclear ruthenium organometallic compounds induce DNA damage in human cells identified by the nucleotide excision repair factor XPC
Ruthenium organometallic compounds represent an attractive avenue in developing alternatives to platinum-based chemotherapeutic agents. While evidence has been presented indicating ruthenium-based compounds interact with isolated DNA in vitro, it is unclear what effect these compounds exert in cells...
Autores principales: | Fast, Olivia G., Gentry, Brittany, Strouth, Liah, Niece, Madison B., Beckford, Floyd A., Shell, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629949/ https://www.ncbi.nlm.nih.gov/pubmed/31227614 http://dx.doi.org/10.1042/BSR20190378 |
Ejemplares similares
-
SUMO and ubiquitin-dependent XPC exchange drives nucleotide excision repair
por: van Cuijk, Loes, et al.
Publicado: (2015) -
Histone deacetylation regulates nucleotide excision repair through an interaction with the XPC protein
por: Kusakabe, Masayuki, et al.
Publicado: (2022) -
Nucleotide excision repair in Human cell lines lacking both XPC and CSB proteins
por: Lindsey-Boltz, Laura A, et al.
Publicado: (2023) -
Recognition of DNA damage by XPC coincides with disruption of the
XPC–RAD23 complex
por: Bergink, Steven, et al.
Publicado: (2012) -
Organometallic cis-Dichlorido Ruthenium(II) Ammine Complexes
por: Betanzos-Lara, Soledad, et al.
Publicado: (2011)